Marlene Born
Director of Finance/CFO presso DOTTIKON ES HOLDING AG
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Marlene Born è Chief Financial Officer presso la Dottikon Es Holding AG e Vicepresidente della Fondazione per il benessere sociale presso la Dottikon Exclusive Synthesis AG e membro del consiglio di amministrazione della Dottikon Es Management AG (entrambe le società sono controllate dalla Dottikon Es Holding AG). La signora Born è anche nel consiglio di amministrazione della Evolma Holding AG e della Systag System Technik AG, nonché vicepresidente della Fondazione per il benessere sociale della Dottikon Exclusive Synthesis AG e membro del consiglio di amministrazione della Dottikon Es Management AG. In passato la signora Born ha ricoperto la posizione di contabile della Aerzte Treuhand G Deragisch, di controller presso la ABB Normelec AG e di responsabile della contabilità presso la Migros Verteilzentrum Suhr AG.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
DOTTIKON ES HOLDING AG
0.05% | 31/03/2023 | 6 412 ( 0.05% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Marlene Born
| Società | Posizione | Inizio |
|---|---|---|
| DOTTIKON ES HOLDING AG | Director of Finance/CFO | 01/01/2006 |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | 20/12/2010 |
| Evolma Holding AG | Director/Board Member | - |
Systag System Technik AG
 Systag System Technik AG Medical SpecialtiesHealth Technology Systag System Technik AG specializes in laboratory automation. The private company is based in Ruschlikon, Switzerland. The Swiss company has been a leading partner for chemical and pharmaceutical production facilities worldwide since 1965. The CEO of the company is Marcel Haugg. | Director/Board Member | - |
| Dottikon Es Management AG | Corporate Officer/Principal | - |
Precedenti posizioni note di Marlene Born
| Società | Posizione | Fine |
|---|---|---|
| Migros Verteilzentrum Suhr AG | Comptroller/Controller/Auditor | 01/01/2005 |
| Aerzte Treuhand G Deragisch | Comptroller/Controller/Auditor | 01/01/2000 |
| ABB Normelec AG | Comptroller/Controller/Auditor | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DOTTIKON ES HOLDING AG | Process Industries |
| Aziende private | 7 |
|---|---|
| Evolma Holding AG | |
Systag System Technik AG
Systag System Technik AG Medical SpecialtiesHealth Technology Systag System Technik AG specializes in laboratory automation. The private company is based in Ruschlikon, Switzerland. The Swiss company has been a leading partner for chemical and pharmaceutical production facilities worldwide since 1965. The CEO of the company is Marcel Haugg. | Health Technology |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
| Migros Verteilzentrum Suhr AG | |
| ABB Normelec AG | |
| Dottikon Es Management AG | |
| Aerzte Treuhand G Deragisch |
- Borsa valori
- Insiders
- Marlene Born
